Actin and myosin are the two protein filaments that generate force inside every muscle cell in your body. They work by sliding past each other in a repeating cycle powered by ATP, the cell’s energy currency, and the interaction between them is what turns a chemical signal from your nervous system into physical movement. The basic mechanism was identified in the 1950s, but the details of how these two proteins are regulated, how they differ across muscle types, and what happens when they malfunction continue to drive major areas of biomedical research.
Two Filaments That Slide
Muscle cells are packed with repeating units called sarcomeres, and each sarcomere contains two overlapping sets of filaments. The thick filaments are built mainly from myosin, and the thin filaments are built mainly from actin. When a muscle contracts, these filaments do not themselves shorten. Instead, the myosin-containing thick filaments pull the actin-containing thin filaments inward, so the two sets slide past each other and the sarcomere gets shorter. Scale that up across millions of sarcomeres in a muscle fiber, and you get visible movement.
This “sliding filament” idea was put forward independently in 1954 by two unrelated scientists who happened to share the surname Huxley, along with their respective collaborators. Hugh Huxley and Jean Hanson showed that the filaments overlap and slide rather than crumple or fold, overturning older ideas about how contraction worked.1PubMed Central. Muscle contraction: Sliding filament history, sarcomere dynamics and the two Huxleys The model has held up for seven decades and remains the foundation of muscle physiology.2PubMed Central. Hugh E. Huxley: the compleat biophysicist
Actin and myosin do not float freely inside the sarcomere. They are held in precise alignment by a scaffolding of additional proteins, including the giant molecule titin (which acts like a molecular spring connecting each thick filament to the ends of the sarcomere) and nebulin (which runs along the thin filament and helps set its length). Other structural proteins like alpha-actinin and myomesin anchor the filaments at the sarcomere’s boundaries and midline.3PubMed. The sarcomeric cytoskeleton: who picks up the strain? Without this scaffolding, the sliding mechanism would have no framework to push against.
The Power Stroke
The actual force-producing event is called the power stroke, and it happens at the molecular level on each individual myosin head. A myosin molecule has a long tail that bundles into the thick filament and a globular head that reaches outward toward the thin filament. When conditions are right, the head attaches to a binding site on actin, then undergoes a shape change that swings a lever-like arm roughly 60 degrees, pulling the actin filament a short distance along.4PubMed Central. Structural mechanism of the recovery stroke in the myosin molecular motor That conformational change in the globular head is driven by the energy released from splitting ATP.5PubMed. Mechanics of the power stroke in myosin II
After the stroke, a fresh ATP molecule binds to the myosin head and causes it to detach from actin. The head then resets (a step called the recovery stroke), reattaches further along the actin filament, and fires again. This attach-pull-release-reset sequence is called the cross-bridge cycle, and it repeats rapidly for as long as the muscle is being told to contract. Modeling work on skeletal muscle suggests the stroke itself may occur in two substeps, with displacements of roughly 5.6 and 4.6 nanometers, which together allow an efficiency of up to about 38 percent during shortening.6PubMed Central. A cross-bridge cycle with two tension-generating steps simulates skeletal muscle mechanics
The power stroke is not strictly a one-way event. Optical-trap experiments on single myosin motor heads have shown that if load is applied to the head immediately after it binds actin, the stroke can actually reverse, with the head fluctuating between pre- and post-power-stroke positions.7PubMed Central. Direct observation of the myosin-Va power stroke and its reversal Under normal conditions in a working muscle, the cycle proceeds forward because the chemical energy from ATP keeps pushing it that way. But the reversibility shows that the power stroke is a mechanically sensitive step, not a simple ratchet.
Calcium Flips the Switch
Myosin would happily bind to actin all the time if nothing stopped it. The reason your muscles are not permanently locked in contraction is that the myosin-binding sites on actin are physically blocked when the muscle is at rest. Two regulatory proteins, tropomyosin and troponin, handle this job in skeletal and cardiac muscle. Tropomyosin is a long, rope-like molecule that winds along the groove of the actin filament, and at low calcium concentrations, troponin pins tropomyosin in a position that covers the sites where myosin heads need to attach.8PubMed Central. Structural basis for the activation of muscle contraction by troponin and tropomyosin
When calcium floods into the cell (more on how that happens shortly), calcium ions bind to a subunit of troponin and cause it to release its grip on actin. This lets tropomyosin shift back toward the groove of the actin double helix, uncovering the myosin-binding sites and allowing cross-bridge cycling to begin.9PubMed Central. Mechanism of the calcium-regulation of muscle contraction–in pursuit of its structural basis When calcium is pumped back out of the vicinity, troponin re-engages, tropomyosin slides back over the binding sites, and the muscle relaxes. The whole system is elegantly binary at the level of each binding site: calcium present means “go,” calcium absent means “stop.”
Smooth Muscle Plays by Different Rules
The troponin-tropomyosin switch described above operates in striated muscles, meaning skeletal muscle and heart muscle. Smooth muscle, the type that lines your blood vessels, digestive tract, and airways, lacks troponin entirely and uses a fundamentally different activation pathway. Instead of unblocking the actin filament, smooth muscle activates the myosin side of the equation.
When calcium rises inside a smooth muscle cell, it binds to a protein called calmodulin. The calcium-calmodulin complex then activates an enzyme called myosin light chain kinase, which adds a phosphate group to one of myosin’s small subunits (called the regulatory light chain). Only after that phosphorylation event can smooth muscle myosin bind to actin and begin cycling.10PubMed. Calmodulin and the regulation of smooth muscle contraction11Journal of Biological Chemistry. Ca2+ Activation of Smooth Muscle Contraction: EVIDENCE FOR THE INVOLVEMENT OF CALMODULIN THAT IS BOUND TO THE TRITON-INSOLUBLE FRACTION EVEN IN THE ABSENCE OF Ca2+ Additional signaling pathways, such as the RhoA/ROCK pathway, help maintain sustained tone in smooth muscle even after the initial calcium signal fades.12PubMed Central. Ca2+/calmodulin/MLCK pathway initiates, and RhoA/ROCK maintains, the internal anal sphincter smooth muscle tone
This difference matters clinically. Drugs designed to affect smooth muscle contraction (for example, medications that relax blood vessels to lower blood pressure) often target the calmodulin-kinase pathway rather than the troponin-tropomyosin system. The two muscle types share the same core actin-myosin engine, but the regulatory wiring around it is quite different.
Getting Calcium to the Filaments
Calcium does not simply drift into the muscle cell when you decide to move your arm. The process of converting a nerve signal into a calcium release, and therefore into contraction, is called excitation-contraction coupling. It happens at specialized junctions inside the muscle fiber where the cell membrane dips inward (in structures called T-tubules) and comes very close to the sarcoplasmic reticulum, an internal calcium warehouse.
When an electrical signal from a motor neuron arrives at the muscle fiber, it travels along the cell membrane and down the T-tubules. Voltage-sensing proteins embedded in the T-tubule membrane (dihydropyridine receptors) detect the electrical change and communicate with calcium release channels on the sarcoplasmic reticulum (type 1 ryanodine receptors, or RyR1).13PubMed Central. In situ structural insights into the excitation-contraction coupling mechanism of skeletal muscle In skeletal muscle, this communication is mechanical: the voltage sensor physically pokes the ryanodine receptor open. In heart muscle, the voltage sensor lets a small amount of calcium in from outside the cell, and that calcium triggers the ryanodine receptor to release a much larger flood from the sarcoplasmic reticulum.
The ryanodine receptor is essential to this process. If the specific region of RyR1 needed for coupling to the voltage sensor is lost, the channel can still release calcium on its own, but it no longer responds to the electrical signal from the T-tubule, and excitation-contraction coupling fails.14Journal of Biological Chemistry. A Region of the Ryanodine Receptor Critical for Excitation-Contraction Coupling in Skeletal Muscle Defects in ryanodine receptors are implicated in conditions ranging from malignant hyperthermia (a dangerous reaction to certain anesthetics) to some forms of cardiac arrhythmia.15PubMed Central. Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor
Fast Fibers, Slow Fibers, and the Myosin Isoforms Behind Them
Not all actin-myosin interactions are created equal. Your body contains different types of muscle fibers, and much of the difference in their contractile speed comes down to which version of myosin they express. Myosin exists in several isoforms, each encoded by a different gene, and these isoforms cycle through the cross-bridge process at different rates.
In human skeletal muscle, type I (“slow-twitch”) fibers contain myosin heavy chain I (MHCI), which produces force slowly but efficiently and resists fatigue. Type IIA fibers contain MHCIIa, which contracts at an intermediate speed. Type IIB fibers (sometimes called IIX in humans) contain the fastest isoform.16PubMed. Correlation between myofibrillar ATPase activity and myosin heavy chain composition in single human muscle fibers Measurements of stretch activation kinetics in human fibers confirm this hierarchy: MHCIIb fibers respond fastest and MHCI fibers respond slowest, with MHCIIa in between.17FEBS Letters. Kinetic properties of myosin heavy chain isoforms in single fibers from human skeletal muscle Many fibers are “hybrid,” expressing more than one isoform simultaneously, and their properties fall somewhere along the continuum.
The difference between a sprinter’s explosive power and a marathon runner’s endurance is partly a matter of fiber-type distribution, which is influenced by genetics and shaped by training. Endurance training nudges fibers toward the slow end of the spectrum, while high-intensity resistance work encourages faster isoform expression. But the fundamental speed limit of each fiber type is set by the kinetics of its myosin molecules.
Force, Speed, and the Energy Bill
A muscle’s output is not just about how many cross-bridges are firing. There is a well-known trade-off between force and shortening speed: a muscle that is lifting a heavy load contracts slowly, while the same muscle shortening against a light load moves quickly. This relationship follows a curve first described by A.V. Hill in 1938 and now understood to reflect the cyclic actin-myosin interaction coupled with ATP hydrolysis.18PubMed Central. Physiological Significance of the Force-Velocity Relation in Skeletal Muscle and Muscle Fibers At the molecular level, when the load is high, each myosin head stays attached to actin longer and moves the filament a shorter distance per cycle. When the load is light, heads detach and reattach quickly, moving the filament faster but producing less force per individual stroke.
Fueling all of this is ATP, and the demand during intense exercise can be enormous. High-intensity contractions can increase the rate of ATP consumption by roughly a thousand-fold compared to rest.19PubMed Central. Interaction among Skeletal Muscle Metabolic Energy Systems during Intense Exercise Three systems work in concert to regenerate ATP: the phosphagen system (immediate, lasts seconds), the glycolytic system (fast, fuels efforts lasting up to a couple of minutes), and mitochondrial respiration (slower to ramp up but sustainable for hours). Which system dominates at any moment depends on how hard and how long the muscle is working. The sensation of muscle fatigue is partly a matter of these energy systems struggling to keep up with the cross-bridge cycle’s appetite for ATP.
Fine-Tuning the Cross-Bridge
The cross-bridge cycle is not simply an on-off affair even within a single muscle fiber. Accessory proteins fine-tune how quickly myosin heads bind actin, how long they stay attached, and how much force each stroke produces. One of the most important regulators in the heart is cardiac myosin-binding protein C (cMyBPC). In its unphosphorylated form, cMyBPC slows down the rate at which myosin attaches to and detaches from actin, acting as a brake. When cMyBPC is phosphorylated (for example, during the fight-or-flight response when adrenaline surges), that braking effect is largely abolished, allowing faster cross-bridge cycling and stronger, quicker heartbeats.20PubMed Central. Cardiac myosin binding protein C and its phosphorylation regulate multiple steps in the cross-bridge cycle of muscle contraction
Another layer of regulation involves a state called the “super relaxed state,” in which a large fraction of myosin heads are folded back against the thick filament and essentially parked, consuming very little ATP. This reserve pool can be mobilized when the heart needs more force, for instance during exercise. Phosphorylation of the myosin regulatory light chain destabilizes the super relaxed state, freeing heads to move toward the thin filament and participate in contraction.21Journal of Biological Chemistry. Cardiac myosin contraction and mechanotransduction in health and disease This parking-and-mobilization system gives the heart a way to adjust its output on a beat-to-beat basis without changing the number of muscle cells involved.
Actin and Myosin Outside of Muscle
Actin and myosin are not exclusive to muscle. Nearly every cell in your body uses a version of these proteins. Non-muscle myosin II, for instance, generates the forces that pull a cell apart during cell division, help cells crawl during wound healing, and maintain cell shape.22PubMed Central. Nonmuscle myosin-2: mix and match The fundamental mechanism is the same: myosin heads walk along actin filaments using ATP, producing force. But non-muscle cells organize these filaments into temporary, dynamic networks rather than the rigid sarcomere arrays found in muscle.
Other myosin family members have specialized roles that go well beyond contraction. Myosin-19, for example, is a motor that moves along actin filaments near mitochondria and helps stabilize contact sites between mitochondria and the endoplasmic reticulum. Its activity is spatially regulated by tropomyosin isoforms that associate with actin filaments near mitochondria and cooperatively inhibit myosin-19’s movement.23PubMed Central. Non-muscle tropomyosins inhibit myosin-19 and dynamically localize to mitochondrially associated actin filaments Tropomyosin, in other words, is not just a muscle protein. It is a universal gatekeeper that decides which myosins can travel on which actin tracks, across many cell types.
When Mutations Disrupt the Machinery
Because actin and myosin sit at the very center of muscle function, mutations in the genes encoding either protein (or their regulatory partners) can cause serious disease. The consequences depend on which protein is affected and where in the molecule the mutation falls.
Mutations in the gene for beta-cardiac myosin are among the most common causes of hypertrophic cardiomyopathy, a condition in which the heart muscle thickens abnormally and can cause sudden cardiac death in young people. Some of these mutations make individual myosin molecules produce more force than normal. Two early-onset mutations studied in human beta-cardiac myosin increased the force per molecule by roughly 23 to 46 percent compared to the normal protein.24Cell Reports. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin Others work by destabilizing the super relaxed state, freeing too many myosin heads and generating excessive contractile force.25PubMed Central. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state Over time, the heart responds to this chronic overwork by thickening, which can impair its ability to fill with blood and increases the risk of dangerous heart rhythms.
On the actin side, mutations in the skeletal muscle alpha-actin gene (ACTA1) cause a group of disorders called nemaline myopathies. These are characterized by muscle weakness and the accumulation of rod-shaped protein aggregates in muscle fibers.26PubMed Central. Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene The clinical severity varies enormously depending on where in the actin molecule the mutation sits. Some mutations prevent myosin from binding properly, limiting the number of cross-bridges that can form and dramatically reducing force production.27PLOS ONE. Nemaline Myopathy-Related Skeletal Muscle α-Actin (ACTA1) Mutation, Asp286Gly, Prevents Proper Strong Myosin Binding and Triggers Muscle Weakness Others disrupt the internal structure of the sarcomere. Milder forms of actin-related myopathy have been linked to compensatory upregulation of cardiac alpha-actin, an isoform normally dominant in the prenatal skeleton and the adult heart, which may partially substitute for the defective skeletal isoform.28PubMed Central. ACTA1‐Related Adult‐Onset Scapuloperoneal Myopathy With Cores and Rods
Drugs That Target the Motor
Understanding how actin and myosin interact at the molecular level has opened the door to drugs that directly tune the motor rather than working through hormones or the nervous system. One of the most notable is omecamtiv mecarbil, a cardiac myosin activator developed for heart failure. The drug’s mechanism illustrates how precise the pharmacology has become: modeling work suggests it narrows the energy difference between the pre- and post-power-stroke positions and raises the activation energy needed for the lever arm swing, effectively slowing the individual stroke but increasing the total fraction of time each head spends bound to actin and generating force.29PubMed Central. Mechanistic insights into effects of the cardiac myosin activator omecamtiv mecarbil from mechanokinetic modelling The net effect is a longer, more sustained contraction of the heart muscle without the large increases in energy consumption caused by traditional stimulants.
On the opposite side of the spectrum, mavacamten, approved for obstructive hypertrophic cardiomyopathy, works by stabilizing the super relaxed state, parking more myosin heads and reducing the excessive force production that drives the disease. These two drugs exemplify a broader principle: the actin-myosin system has so many tunable steps that pharmacologists can aim for very specific effects, boosting contraction in a failing heart or dampening it in one that contracts too forcefully.
An Evolutionary Perspective on Collective Motor Action
The cross-bridge cycle did not arrive fully optimized. Evolutionary modeling suggests that the cooperative behavior of myosin II motors, where many heads work together on a single thick filament, has been shaped by natural selection acting on at least three properties: how readily each head binds actin, the strength of the power stroke, and how force influences the rate at which the head lets go. These variables interact in nonlinear ways, meaning the collective output of many motors is not simply the sum of what each one would produce alone.30PubMed Central. Evolution of mechanical cooperativity among myosin II motors One consequence of this is the speed-efficiency trade-off seen across different tissues: fast muscles sacrifice efficiency for speed, while slow muscles and cardiac muscle optimize for endurance and economy. The tuning knobs are the same few molecular properties, dialed differently in each tissue to match its job.